Get Started

Pro Life Catholic Investments Cannot Include Stem Cell or Cloning Companies

<<< Back to All Exclusions

No Potential Scientific or Financial Good Can Cost the Life of Another

“No objective, even though noble in itself, such as a foreseeable advantage to science, to other human beings or to society, can in any way justify experimentation on living human embryos or fetuses, whether viable or not, either inside or outside the mother’s womb. To use human embryos or fetuses as the object or instrument of experimentation constitutes a crime against their dignity as human beings having a right to the same respect that is due to the child already born and to every human person.”USCCB Investing Guidelines

Impact Investing Affected Scientist Working on CloningIt has become a cliché phrase, but the moral truth still holds: the ends do not justify the means. If achieving real benefits through evil actions is not morally legitimate, how much worse must performing evil actions for hypothetical gains be? Both the scientific and financial world need to learn this lesson with regards to human cloning and stem cell research.

Even the greatest investment or scientific breakthrough cannot justify violating the dignity of another human being.

Schedule Free Consultation Today
It’s easy to chase the pie-in-the-sky promised by so much scientific research, especially when the evil involved is out of sight. Rapid developments in biotech have made life better for countless individuals, with major financial rewards for investors as well. As Catholics, though, we cannot ignore the real human cost of the relentless, senseless pursuit of a hypothetical cure for certain diseases and the huge monetary gains that would might follow but that are just as hypothetical.

Catholic Financial Advisors Do More Than Just Avoid Investing in Morally Evil Practices

Instead of going along with the world and supporting morally evil research in the name of progress and money, Catholic investors must take the high road. Fortunately, the financial advisors at Summit have created a series of investment portfolios carefully eliminating all companies that have been found to be engaged in immoral stem cell research and cloning.

Catholic investors can rest easy knowing their investments will never knowingly support the destruction of or experimentation on human embryos.

More than just investing elsewhere and holding the moral high ground, Catholics are called by the USCCB to work to stop these evil practices. Summit has responded by engaging corporate leadership in fruitful dialogue to curb and eliminate morally wrong activities. There is still a long way to go, but by investing with Summit, you can be sure you will not only avoid doing evil, but also actively promote ending stem cell and cloning research.

Contact our Catholic financial advisors for a free consultation on investing without supporting stem cell or cloning research.

Back to All Exclusions